Vitrolife Competitors and Similar CompaniesClear all
Vitrolife's competitors and similar companies include Novadip Biosciences, Cell Genesys, Fulcrum Therapeutics and Annexon Biosciences.
 Vitrolife Vitrolife is a biotechnology company that develops products to counter fertility issues in humans. |  Cell Genesys Here at Cell Genesys, we bring you the latest health news on gene therapy, vaccination, and other health related issues the world is facing today. |  Fulcrum Therapeutics We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are. |  Annexon Biosciences Annexon Biosciences is a clinical-stage biopharmaceutical company that develops complementary medicines for patients with complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye. | ||
Founding Date | Founding Date 1981 | Founding Date 2013 | Founding Date 1988 | Founding Date 2016 | Founding Date 2011 |
Type | Type Public | Type Private | Type Private | Type Public | Type Public |
Tags | |||||
Locations | Locations Västra Frölunda, SE HQ | Locations Mont-Saint-Guibert, BE HQ | Locations Roosevelt, US HQ | Locations Cambridge, US HQ | Locations Brisbane, US HQ |
Employees | Employees 1,150 | Employees 542% increase | Employees 89 | Employees 43223% increase | Employees 10041% increase |
Valuation ($) | Valuation ($) 3.1 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 202.2 m | Valuation ($) 799.8 m |
Financial | |||||
Net income | Net income (kr5b) (FY, 2025) | Net income N/A | Net income N/A | Net income ($74.9m) (FY, 2025) | Net income ($206.7m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 31.3m | Total funding raised N/A | Total funding raised $ 55m | Total funding raised $ 179m |
For sources of this data, please see the company profile
View Company Profiles
Novadip Biosciences
HQ
Mont-Saint-Guibert, BE
Employees
54↑ 2% increase
Novadip Biosciences is a biopharmaceutical company.
View companyCell Genesys
HQ
Roosevelt, US
Employees
89
Here at Cell Genesys, we bring you the latest health news on gene therapy, vaccination, and other health related issues the world is facing today.
View companyFulcrum Therapeutics
HQ
Cambridge, US
Employees
432↑ 23% increase
We are here to develop new medicines to deliver a new future for patients and their families by transforming gene regulation in disease. Above all we are champions for our patients. Trust, Respect, Compassion and Integrity define who we are.
View companyAnnexon Biosciences
HQ
Brisbane, US
Employees
100↑ 41% increase
Annexon Biosciences is a clinical-stage biopharmaceutical company that develops complementary medicines for patients with complement-mediated autoimmune, neurodegenerative, and ophthalmic disorders of the body, brain, and eye.
View company